Buscar en
Cirugía Española
Toda la web
Inicio Cirugía Española Diferencias clinicobiológicas de los carcinomas ductales infiltrantes de mama C...
Información de la revista
Vol. 69. Núm. 5.
Páginas 451-454 (Mayo 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 69. Núm. 5.
Páginas 451-454 (Mayo 2001)
Acceso a texto completo
Diferencias clinicobiológicas de los carcinomas ductales infiltrantes de mama CD44v5 positivos clasificados en función de la concentración de ácido hialurónico de la membrana celular
Clinical and Biological Differences between CD44v5 Positive Infiltrating Ductal Carcinomas of the Breast, Classified on the Basis of Hyaluronic Acid Concentration in the Cell Membrane
Visitas
4421
A. Ruibal1,*,**, J. Arias***, A. Suárez****, M.C. del Río*****, G. Lapeña*,**, J. Schneider**,******, A. Tejerina**,******
* Servicio de Medicina Nuclear. Fundación Jiménez Díaz. Madrid.
** Fundación Tejerina. Madrid.
*** Servicio de Cirugía General. Hospital Monte del Naranco. Oviedo.
**** Servicio de Cirugía General. Fundación Jiménez Díaz. Madrid.
**** Servicio de Bioquímica. Hospital de Barbanza. Ribeira. La Coruña.
***** Centro de Patología de la Mama. Madrid.
Este artículo ha recibido
Información del artículo
Resumen
Introducción

El CD44 es una molécula de adhesión celular de la que se conocen una forma estándar (CD44s) y varias isoformas variantes (CD44v) y cuyo principal ligando es el ácido hialurónico (AH), proteglicano de la matriz extracelular implicado en numerosas acciones biológicas. En este estudio hemos querido analizar la posible influencia de la concentración de AH sobre ciertas propiedades clinicobiológicas de los carcinomas ductales infiltrantes de mama CD44v5 positivos.

Pacientes y métodos

Se han determinado en 124 carcinomas ductales infiltrantes de mama CD44v5 positivos (56 AH positivos [> 1.500 ng/mg de proteína] y 68 AH negativos) las concentraciones citosólicas de receptores de estrógenos (RE), de progesterona (RP), ps2, catepsina D y activador del plasminógeno tipo tisular (t-AP). Se ha considerado también el tamaño tumoral, afección ganglionar axilar (N), el grado histológico (GH), ploidía y la fase de síntesis celular (FS).

Resultados

Los tumores AH positivos presentaron menores concentraciones de catepsina D (p = 0,013) que los AH negativos. Asimismo, fueron menos frecuentemente aneuploides (p = 0,026), catepsina D positivos (p = 0,015), GH 3 (p = 0,043) y proliferativos (FS > 7%; p = 0,049).

Conclusiones

Los resultados anteriores sugieren que la concentración de ácido hialurónico en la membrana celular podría asociarse con ciertas propiedades clinicobiológicas de los carcinomas ductales infiltrantes de mama CD44v5 positivos.

Palabras clave:
Carcinomas mamarios
CD44v5
Ácido hialurónico
Introduction

CD44 is a cell adhesion molecule. There is one standard form, CD44s, and many variant isoforms, CD44v; their main ligand is hyaluronic acid, which is a proteoglycan found in the extracellular matrix and is involved in various biological functions. In this study we analyzed whether hyaluronic acid levels in the cell membrane modulated certain clinical and biological features of CD44v5-positive infiltrating ductal carcinomas of the breast.

Patients and methods

We determined 124 patients with CD44v5-positive infiltrating ductal carcinoma of the breast. Of these, 56 were hyaluronic positive (> 1,500 ng/mg prot.) and 68 were negative. We measured the cytoplasmic levels of oestrogen receptors, progesterone receptors, ps2, cathepsin D, and tissue-type plasminogen activator. Tumour size, axillary lymph node involvement, histological grade, ploidy and Sphase of cell cycle were also taken into account.

Results

Hyaluronic positive tumors had lower concentrations of cathepsin D (p = 0.013) than hyaluronic negative tumors. They were also less frequently aneuploid (p = 0.026) and cathepsin D positive (p = 0.015), histological grade 3 (p = 0.043) and S-phase > 7% (p = 0.049).

Conclusions

Our results suggest that hyaluronic acid concentrations in the cell membrane may be associated with some clinical and biological differences between CD44v5-positive infiltrating ductal carcinomas of the breast.

Key words:
Breast tumors
CD44v5
Hyaluronic acid
El Texto completo está disponible en PDF
Bibliografía
[1.]
A. Herrera-Gayol, S. Jothy.
CD44 modulates Hs5787T human breast cancer cell adhesion, migration and invasiveness.
Exp Mol Pathol, 66 (1999), pp. 99-108
[2.]
V. Ladeda, J.A. Aguirre Ghiso, E. Bal de Kier Joffe.
Function and expression of CD44 during spreading, migration and invasion of murine carcinoma cells.
Exp Cell Res, 242 (1998), pp. 515-527
[3.]
C. Kainz, C. Tempfer.
CD44 as a differentiation marker and metastasis promoter in gynecological malignancies.
The Cancer Journal, 10 (1997), pp. 306-309
[4.]
C. Underhill.
CD44: The hyaluronan receptor.
J Cell Science, 103 (1992), pp. 293-298
[5.]
K. Kimata, Y. Honma, M. Okayama, K. Oguri, M. Hozumi, S. Suzuki.
Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential.
Cancer Res, 43 (1983), pp. 1347-1354
[6.]
P. Bertrand, N. Girard, B. Delpech, C. Duval, J. D’Anjou, J.P. Dauce.
Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of breast carcinomas: comparison between invasive and non invasive areas.
Int J Cancer, 52 (1992), pp. 1-6
[7.]
V.B. Lokeshwar, M.J. Young, G. Goudarzi, N. Iida, A.I. Yudin, G.N. Cherr, et al.
Identification of bladder tumor-derived hyaluronidase: its similarity to HYAL1.
Cancer Res, 59 (1999), pp. 4464-4470
[8.]
A.K. Madan, K. Yu, N. Dhurandhar, C. Cullinane, V. Pang, D.J. Beech.
Association of hyaluronidase and breast adenocarcinoma invasiveness.
Oncol Rep, 6 (1999), pp. 607-609
[9.]
N. Itano, T. Sawai, O. Miyaishi, K. Kimata.
Relationship between hyaluronan production and metastatic potential of mouse mammary carcinoma cells.
Cancer Res, 59 (1999), pp. 2499-2504
[10.]
R. Victor, C. Chauzy, N. Girard, J. Gionni, J. D’Anjou, H. Stora De Novion, et al.
Human breast-cancer metastasis formation in a nudemouse model: studies of hyaluronidase, hyaluronan and hyaluronanbinding sites in metastatic cells.
Int J Cancer, 82 (1999), pp. 77-83
[11.]
K.J. Till, M. Zuzel, J.C. Cawley.
The role of hyaluronan and interleukin 8 in the migration of chronic lymphocytic leukemia cells within lymphoreticular tissues.
Cancer Res, 59 (1999), pp. 4419-4426
[12.]
L.R. Ylagan, B. Quinn.
CD44 expression in astrocytic tumors.
Mod Pathol, 10 (1997), pp. 1239-1246
[13.]
S. Gunia, S. Hussein, D.L. Radu, K.M. Putz, R. Breyer, H. Hecker, et al.
CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma.
Clin Exp Metastasis, 17 (1999), pp. 221-230
[14.]
H.P. Sinn, K.H. Heider, P. Skroch-Angel, G. Von Minckwitz, M. Kaufamann, P. Herrlich, et al.
Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Breast Cancer Res Treat, 36 (1995), pp. 307-313
[15.]
M. Kaufmann, K.H. Heider, H.P. Sinn, G. von Minckwitz, H. Ponta, P. Herrlich.
CD44 variant exon epitopes in primary breast cancer and length of survival.
Lancet, 345 (1995), pp. 615-619
[16.]
R. Ristamaki, H. Joensuu, K.O. Sonderstrom, S. Jalkanen.
CD44v6 expression in non-Hodgkin’s lymphoma: an association with low histological grade and poor prognosis.
J Pathol, 176 (1995), pp. 259-267
[17.]
L. Hefler, C. Tempfer, G. Haeusler, E. Kucera, K. Mayerhofer, R. Seillinger, et al.
Cytosol concentrations of CD44 isoforms in breast cancer tissue.
Int J Cancer, 79 (1998), pp. 541-545
[18.]
C. Tempfer, A. Losch, H. Heinzl, G. Hausler, E. Hanzal, H. Kolb, et al.
Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer.
Eur J Cancer, 32 (1996), pp. 2023-2025
[19.]
M.I. Núñez, J.I. Arias, M.C. Del Río, M.I. Martínez, A. Alba, M.T. Allende, et al.
Cell surface CD44v5 levels correlate with progesterone receptors and a tumor size > 2 cm in infiltrating ductal carcinoma of the breast.
Int J Biol Markers, 11 (1996), pp. 220-222
[20.]
M.M. Knupfer, H. Poppenborg, M. Hostfilder, K. Kuhnel, J.E. Wolff, M. Domula.
CD44 expression and hyaluronic binding of malignant glioma cells.
Clin Exp Metastasis, 17 (1999), pp. 71-76
[21.]
Q. Yu, I. Stamenkovic.
Localization of matrix metalloproteinase 9 to cell surface provides a mechanism for CD44-mediated tumor invasion.
Genes Dev, 13 (1999), pp. 35-48
[22.]
Q. Yu, B.P. Toole, I. Stamenkovic.
Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.
J Exp Med, 186 (1997), pp. 1985-1996
[23.]
J. Hitzemen, P.G. Woost, H.L. Hosick.
Correlation of hyaluronic acid accumulation and the growth of preneoplastic mammary cells in collagen: a longitudinal study.
In Vitro Cell Dev Biol, 28 (1992), pp. 284-292
[24.]
M. Culty, M. Shizari, E.W. Thompson, C.B. Underhill.
Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential.
J Cell Physiol, 160 (1994), pp. 275-286
[25.]
J.A. Foekens, M.P. Look, J. Bolt-De Vries, M.E. Meijer-Van Gelder, W.L. Van Putten, J.G. Klijn.
Cathepsin D in primary breast cancer: prognostic evaluation involving 2810 patients.
Br J Cancer, 79 (1999), pp. 300-307
[26.]
T.E. Witzig, J.N. Ingle, S.S. Cha, D.J. Schaid, R.L. Tabery, L.E. Wold, et al.
DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer.
Cancer, 74 (1994), pp. 1752-1761
[27.]
D. Mink, B. Von Tongelen, C. Villena-Heisen, C. Heiss, W. Schmidt.
Breast cancer and prognostic factors. Tumor size, degree of differentiation, proliferation kinetics and expression of steroid hormone receptors.
Eur J Gynaecol Oncol, 15 (1994), pp. 424-436
Copyright © 2001. Asociación Española de Cirujanos
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos